The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO 2019 | Treating high-risk myeloma in the elderly
Ashley Rosko
• 1 Jun 2019
Many challenges present themselves in the treatment of myeloma in the geriatric population. Ashley Elizabeth Rosko, MD, from Ohio State University, Columbus, OH, discusses these challenges and how to improve treatment outcomes in these patients at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.
